Novartis Investigative Site

Goslar 38642

0 studies enrolling now · 5 studies all time

What they study most

Advanced, Metastatic Breast Cancer, Chronic Iron Overload Due to Transfusion-dependant Anemias, Chronic Myelogenous Leukemia, Metastatic Renal Cell Cancer, Neoplasms, Breast

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) — Completed
• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE